Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 4 |
2023 | 3 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Predictors of Kidney Function Outcomes and Their Relation to SGLT2 Inhibitor Dapagliflozin in Patients with Type 2 Diabetes Mellitus Who Had Chronic Heart Failure.
Adv Ther. 2024 Jan;41(1):292-314. doi: 10.1007/s12325-023-02683-y. Epub 2023 Nov 8.
Adv Ther. 2024.
PMID: 37935870
Free PMC article.
The Effect of SGLT2 Inhibitor Dapagliflozin on Serum Levels of Apelin in T2DM Patients with Heart Failure.
Berezin AA, Fushtey IM, Berezin AE.
Berezin AA, et al. Among authors: fushtey im.
Biomedicines. 2022 Jul 20;10(7):1751. doi: 10.3390/biomedicines10071751.
Biomedicines. 2022.
PMID: 35885056
Free PMC article.
Item in Clipboard
Predictive value of serum irisin for chronic heart failure in patients with type 2 diabetes mellitus.
Berezin AA, Fushtey IM, Pavlov SV, Berezin AE.
Berezin AA, et al. Among authors: fushtey im.
Mol Biomed. 2022 Nov 9;3(1):34. doi: 10.1186/s43556-022-00096-x.
Mol Biomed. 2022.
PMID: 36350412
Free PMC article.
Item in Clipboard
The Impact of SGLT2 Inhibitor Dapagliflozin on Adropin Serum Levels in Men and Women with Type 2 Diabetes Mellitus and Chronic Heart Failure.
Berezin AA, Obradovic Z, Fushtey IM, Berezina TA, Novikov EV, Schmidbauer L, Lichtenauer M, Berezin AE.
Berezin AA, et al. Among authors: fushtey im.
Biomedicines. 2023 Feb 4;11(2):457. doi: 10.3390/biomedicines11020457.
Biomedicines. 2023.
PMID: 36830993
Free PMC article.
Item in Clipboard
Low Plasma Levels of Irisin Predict Acutely Decompensated Heart Failure in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure.
Berezin AA, Obradovic AB, Fushtey IM, Berezina TA, Lichtenauer M, Berezin AE.
Berezin AA, et al. Among authors: fushtey im.
J Cardiovasc Dev Dis. 2023 Mar 23;10(4):136. doi: 10.3390/jcdd10040136.
J Cardiovasc Dev Dis. 2023.
PMID: 37103015
Free PMC article.
Item in Clipboard
Serum Levels of Irisin Predict Cumulative Clinical Outcomes in Heart Failure Patients With Type 2 Diabetes Mellitus.
Berezin AA, Lichtenauer M, Boxhammer E, Fushtey IM, Berezin AE.
Berezin AA, et al. Among authors: fushtey im.
Front Physiol. 2022 May 16;13:922775. doi: 10.3389/fphys.2022.922775. eCollection 2022.
Front Physiol. 2022.
PMID: 35651870
Free PMC article.
Item in Clipboard
Discriminative Utility of Apelin-to-NT-Pro-Brain Natriuretic Peptide Ratio for Heart Failure with Preserved Ejection Fraction among Type 2 Diabetes Mellitus Patients.
Berezin AA, Fushtey IM, Berezin AE.
Berezin AA, et al. Among authors: fushtey im.
J Cardiovasc Dev Dis. 2022 Jan 12;9(1):23. doi: 10.3390/jcdd9010023.
J Cardiovasc Dev Dis. 2022.
PMID: 35050233
Free PMC article.
Item in Clipboard
Cite
Cite